Serum caspase-3 levels during the first week of traumatic brain injury

Author(s):  
L. Lorente ◽  
M.M. Martín ◽  
A. Pérez-Cejas ◽  
A.F. González-Rivero ◽  
M. Argueso ◽  
...  
2001 ◽  
Vol 74 (2) ◽  
pp. 740-753 ◽  
Author(s):  
Robert S. B. Clark ◽  
Patrick M. Kochanek ◽  
Simon C. Watkins ◽  
Minzhi Chen ◽  
C. Edward Dixon ◽  
...  

1999 ◽  
Vol 27 (Supplement) ◽  
pp. 53A
Author(s):  
Robert S. B. Clark ◽  
Patrick M. Kochanek ◽  
Simon C. Watkins ◽  
Minzhi Chen ◽  
Neal A. Seidberg ◽  
...  

Neuroreport ◽  
1998 ◽  
Vol 9 (11) ◽  
pp. 2437-2442 ◽  
Author(s):  
Brian R. Pike ◽  
Xiurong Zhao ◽  
Jennifer K. Newcomb ◽  
Rand M. Posmantur ◽  
Kevin KW Wang ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-16 ◽  
Author(s):  
Yongqi Ye ◽  
Pengju Zhang ◽  
Yuhang Qian ◽  
Baoxin Yin ◽  
Meijuan Yan

WISP1, as a member of the CCN4 protein family, has cell protective effects of promoting cell proliferation and inhibiting cell apoptosis. Although some studies have confirmed that WISP1 is concerned with colon cancer and lung cancer, there is little report about the influence of WISP1 in traumatic brain injury. Here, we found that the expression of WISP1 mRNA and protein decreased at 3 d and then increased at 5 d after traumatic brain injury (TBI). Meanwhile, immunofluorescence demonstrated that there was little colocation of WISP1 with GFAP, Iba1, and WISP1 colocalized with NeuN partly. WISP1 colocalized with LC3, but there was little of colocation about WISP1 with cleaved caspase-3. Subsequent study displayed that the expression ofβ-catenin protein was identical to that of WISP1 after TBI. WISP1 was mainly located in cytoplasm of PC12 or SHSY5Y cells. Compared with the negative control group, WISP1 expression reduced obviously in SHSY5Y cells transfected with WISP1 si-RNA. CCK-8 assay showed that pyrroloquinoline quinone (PQQ) had little influence on viability of PC12 and SHSY5Y cells. These results suggested that WISP1 played a protective role after traumatic brain injury in rats, and this effect might be relative to autophagy caused by traumatic brain injury.


2017 ◽  
Vol 55 (1) ◽  
pp. 898-900
Author(s):  
Firas H. Kobeissy ◽  
Ming Cheng Liu ◽  
Zhihui Yang ◽  
Zhiqun Zhang ◽  
Wenrong Zheng ◽  
...  

2018 ◽  
Vol 35 (1) ◽  
pp. 157-173 ◽  
Author(s):  
Olena Y. Glushakova ◽  
Andriy O. Glushakov ◽  
Cesar V. Borlongan ◽  
Alex B. Valadka ◽  
Ronald L. Hayes ◽  
...  

BMC Neurology ◽  
2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Leonardo Lorente ◽  
María M. Martín ◽  
Mónica Argueso ◽  
Luis Ramos ◽  
Jordi Solé-Violán ◽  
...  

Author(s):  
Retty Ratnawati ◽  
Annisa Nurul Arofah ◽  
Anastasia Novitasari ◽  
Sartika Dewi Utami ◽  
Made Ayu Hariningsih ◽  
...  

<p>BACKGROUND<br />Catechins inhibits apoptosis through anti oxidant and anti inflamation pathway. Catechins also increases brain-derived neurotrophic factor (BDNF). There was a few research that explained the role of catechins in traumatic brain injury (TBI). The objective of the study was to evaluate the effect of catechins administration on neurologic severity score (NSS) through apoptosis and neurotropic pathway in traumatic brain injury rat model.</p><p>METHODS<br />A post test only controlled group design was performed using traumatic brain injury rat (Rattus novergicus) model through weight drop models. It was devided into negative control group, positive control group, TBI+catechins 513 mg/kgBW, TBI+catechins 926 mg/kgBW, TBI+catechins 1113 mg/kgBW. NSS was measured in the first hours, day three, and day seven. The expressions of NFkB, TNFa, Bcl-2, Bax, caspase 3, caspase 8, BDNF, and the numbers of apoptosis cells were evaluated by imunohistochemystry method. One way Anova and Kruskal Wwallis were used to analyse the data.</p><p>Results <br />TNFa, caspase 8, number of apoptosis cells were significantly decreased on the seventh day administration compared to the third day administration (p&lt;0.05). Catechins increased the expression of Bcl-2/Bax and BDNF significantly (p&lt;0.05). Yet, there were no significant differences between expression of caspase 3, NSS, Bcl-2/Bax ratio, and BDNF toward third days administration of catechins compared with seven days administration (p&gt;0.050).</p><p>Conclusions<br />Administration of catechins decreased NSS through inhibiting inflammation and apoptosis, as well as induced the neurotrophic factors in rat brain injury. Catechins may serve as a potential intervention for TBI.</p>


Sign in / Sign up

Export Citation Format

Share Document